Literature DB >> 31799824

Design Rules for Mesoporous Silica toward the Nanosize: A Systematic Study.

Federico Catalano1, Pier Paolo Pompa1.   

Abstract

Mesoporous silica nanoparticles (MSNs) are one of the most frequently employed inorganic materials for catalysis and nanomedicine applications. Nonetheless, a complete control of MSN synthesis parameters aimed at standardizing particle properties is still far from complete, being one of the reasons underlying heterogeneity in their chemical-physical properties, as well as in their biological outcomes. Here, transmission electron microscopy, X-ray diffraction, and volumetric analysis, together with dynamic light scattering and ζ-potential measurements, were combined to carefully characterize different MSNs through a systematic investigation of the role and effectiveness of different factors, such as reaction temperature, time, and pH, on the resulting particle size, texture, and dispersion properties. This methodological approach allowed the implementation of design rules for size-, shape-, and structure-controlled MSNs in the range between 170 and 50 nm.

Entities:  

Keywords:  dispersion; mesoporous silica; nanosize; porosity; size tunability; texture

Year:  2019        PMID: 31799824     DOI: 10.1021/acsami.9b16135

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  2 in total

Review 1.  Progress in Mesoporous Silica Nanoparticles as Drug Delivery Agents for Cancer Treatment.

Authors:  Eleen Dayana Mohamed Isa; Haslina Ahmad; Mohd Basyaruddin Abdul Rahman; Martin R Gill
Journal:  Pharmaceutics       Date:  2021-01-24       Impact factor: 6.321

2.  The pH-triggered drug release and simultaneous carrier decomposition of effervescent SiO2-drug-Na2CO3 composite nanoparticles: to improve the antitumor activity of hydrophobic drugs.

Authors:  Tianyu Chen; Yichun Jiang; Changmao Wang; Zhengxue Cai; Hui Chen; Junliang Zhu; Pinrun Tao; Min Wu
Journal:  RSC Adv       Date:  2021-01-28       Impact factor: 3.361

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.